HOME > ARCHIVE
ARCHIVE
- Asahi Kasei to Focus on 3 Fields
April 23, 2007
- Strict Control of cholesterol Required in Hyperlipidemia Patients with Diabetes
April 23, 2007
- Explosion at Shin-Etsu Chemical Affects Supply of Cellulose Derivatives
April 23, 2007
- Early Treatment of Hepatitis C Needed to Prevent Liver Cancer
April 23, 2007
- System That Reduces Number of Quick Deliveries Needed: Mr Choufuku of Mediceo Paltac
April 23, 2007
- TOPICS/NOXAFIL Recommended for Antifungal Prophylaxis: Schering-Plough
April 23, 2007
- Korosho to Hear Wholesalers, Hospitals, Pharmacies Again Over Agreements on Prices
April 23, 2007
- Bayer Yakuhin to Integrate Nihon Schering in July: Dr Portoff
April 23, 2007
- BUSINESS NEWS IN BRIEF
April 23, 2007
- 27th General Assembly of the Japan Medical Congress
April 23, 2007
- Japan, China, South Korea to Cooperate in Healthcare, Drug Development
April 23, 2007
- Industry's Highest Growth Rate Recorded Twice in 2 Years: NBI
April 16, 2007
- Use of 9 Reagents for Pancreatic Islet Transplantations Restricted
April 16, 2007
- Janssen's Sales Drop 11.8% Due to NHI Price Cuts
April 16, 2007
- MEDICAL DEVICE NEWS IN BRIEF
April 16, 2007
- BUSINESS NEWS IN BRIEF
April 16, 2007
- 26 Complaints Received Regarding Supply of Generics in 1 Year
April 16, 2007
- Abnormal Behavior Reported from 128 Patients after Taking Tamiflu: Korosho
April 16, 2007
- PSJ Luncheon Seminar
April 16, 2007
- Chugai's Grants Go to 3 Institutions Whose Researchers Participate in Tamiflu Survey
April 16, 2007
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
